Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Walther N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Charité Research Organisation GmbH, Berlin, Germany., Schultz-Heienbrok R; Charité Research Organisation GmbH, Berlin, Germany., Staß H; Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany., Corman VM; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany., Gassen NC; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany., Müller MA; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany., Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany., Witzenrath M; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Lung Research, Berlin, Germany., Lee H; Charité Research Organisation GmbH, Berlin, Germany., Posch MG; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. |
| Source: | PloS one [PLoS One] 2025 Feb 25; Vol. 20 (2), pp. e0303924. Date of Electronic Publication: 2025 Feb 25 (Print Publication: 2025). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Comparative Study |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39999124 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Walther+N%22">Walther N</searchLink>; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Charité Research Organisation GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schultz-Heienbrok+R%22">Schultz-Heienbrok R</searchLink>; Charité Research Organisation GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Staß+H%22">Staß H</searchLink>; Bayer AG, Research & Development, Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Corman+VM%22">Corman VM</searchLink>; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany.<br /><searchLink fieldCode="AU" term="%22Gassen+NC%22">Gassen NC</searchLink>; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+MA%22">Müller MA</searchLink>; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany.<br /><searchLink fieldCode="AU" term="%22Drosten+C%22">Drosten C</searchLink>; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Infection Research, Braunschweig, Germany.<br /><searchLink fieldCode="AU" term="%22Witzenrath+M%22">Witzenrath M</searchLink>; Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Lung Research, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Charité Research Organisation GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Posch+MG%22">Posch MG</searchLink>; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2025 Feb 25; Vol. 20 (2), pp. e0303924. <i>Date of Electronic Publication: </i>2025 Feb 25 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39999124 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0303924 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0303924 Titles: – TitleFull: Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Walther N – PersonEntity: Name: NameFull: Schultz-Heienbrok R – PersonEntity: Name: NameFull: Staß H – PersonEntity: Name: NameFull: Corman VM – PersonEntity: Name: NameFull: Gassen NC – PersonEntity: Name: NameFull: Müller MA – PersonEntity: Name: NameFull: Drosten C – PersonEntity: Name: NameFull: Witzenrath M – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Posch MG IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 02 Text: 2025 Feb 25 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 20 – Type: issue Value: 2 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |